fibrinogen has been researched along with iloprost in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajolet, A; Chapoutot, L; Elaerts, J; Graciet, J; Grentzinger, A; Metz, D; N'Guyen, P; Taupin, JM | 1 |
| Cierniewski, CS; Musiał, J; Nizankowski, R; Szczeklik, A; Sładek, K; Wilczyńska, M | 1 |
| Coppola, L; Cozzolino, D; De Lucia, D; Gentile, S; Masi, S; Salvatore, T; Sasso, FC; Torella, R | 1 |
| Gazzaniga, PP; Pulcinelli, FM; Riondino, S | 1 |
| Andrioli, G; Arosio, E; De Marchi, S; Fontana, L; Gaino, S; Lechi, A; Lechi, C; Minuz, P; Prior, M; Zuliani, V | 1 |
3 trial(s) available for fibrinogen and iloprost
| Article | Year |
|---|---|
Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease.
Topics: Adult; Arteriosclerosis Obliterans; Cardiovascular Agents; Epoprostenol; Female; Fibrinogen; Fibrinolysis; Humans; Iloprost; Male; Thromboangiitis Obliterans; Tissue Plasminogen Activator | 1986 |
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
Topics: Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Iloprost; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Treatment Outcome; Walking | 1999 |
Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease.
Topics: Aged; Arteriosclerosis; Blood Glucose; Blood Pressure; Cholesterol; Endothelium, Vascular; Exercise; Fibrinogen; Humans; Iloprost; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Activation; Platelet Function Tests; Treatment Outcome; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2001 |
2 other study(ies) available for fibrinogen and iloprost
| Article | Year |
|---|---|
[Massive pulmonary embolism disclosing thrombocytopenia induced by low molecular weight heparin. Therapeutic success of prostacyclin].
Topics: Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Iloprost; Male; Middle Aged; Phlebitis; Platelet Count; Pulmonary Embolism; Radiography; Thrombocytopenia | 1991 |
Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Blood Platelets; Crotalid Venoms; Cyclic AMP; Cytosol; Diglycerides; Epinephrine; Fibrinogen; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Iloprost; Lectins, C-Type; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2001 |